ZBH · Categories · Upgrades
ZBH - Analyst upgrades
Zimmer Biomet Holdings Inc. (ZBH) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for ZBH
- Zimmer Biomet upgraded by Evercore ISI with a new price targetEvercore ISI upgraded Zimmer Biomet from In-line to Outperform and set a new price target of $210.00
- Zimmer Biomet upgraded by Roth Capital with a new price targetRoth Capital upgraded Zimmer Biomet from Neutral to Buy and set a new price target of $135.00
- Zimmer Biomet upgraded by Analyst with a new price targetAnalyst upgraded Zimmer Biomet from Neutral to Overweight and set a new price target of $128.00 from $125.00 previously
- Zimmer Biomet upgraded by Argus with a new price targetArgus upgraded Zimmer Biomet from Hold to Buy and set a new price target of $150.00
- Zimmer Biomet upgraded by BTIG Research with a new price targetBTIG Research upgraded Zimmer Biomet from Neutral to Buy and set a new price target of $139.00
- Zimmer Biomet upgraded by BofA SecuritiesBofA Securities upgraded Zimmer Biomet from Underperform to Neutral
- Zimmer Biomet upgraded by Evercore ISI with a new price targetEvercore ISI upgraded Zimmer Biomet from In-line to Outperform and set a new price target of $148.00 from $135.00 previously
- Zimmer Biomet upgraded by Jefferies with a new price targetJefferies upgraded Zimmer Biomet from Underperform to Hold and set a new price target of $130.00 from $115.00 previously
- Zimmer Biomet upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Zimmer Biomet from Neutral to Overweight and set a new price target of $145.00 from $135.00 previously
- Zimmer Biomet upgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts upgraded Zimmer Biomet from Sector Perform to Outperform and set a new price target of $141.00 from $125.00 previously
- Zimmer Biomet upgraded by Raymond James with a new price targetRaymond James upgraded Zimmer Biomet from Mkt Perform to Outperform and set a new price target of $144.00
- Zimmer Biomet upgraded by Wells FargoWells Fargo upgraded Zimmer Biomet from Underweight to Equal Weight
- Zimmer Biomet Holdings upgraded by Northland Capital Markets with a new price targetNorthland Capital Markets upgraded Zimmer Biomet Holdings from Market Perform to Outperform and set a new price target of $200.00 from $165.00 previously
- Zimmer Biomet upgraded by Northland Capital with a new price targetNorthland Capital upgraded Zimmer Biomet from Market Perform to Outperform and set a new price target of $2,300.00 from $165.00 previously